NNovo Nordisk Read More Novo Nordisk Combines Direct-to-Patient Service with Analyst Optimism in Obesity Fight2026-05-14 Hedgeye sees up to 117% upside for Novo Nordisk as oral obesity pill prescriptions surge; home delivery via…